Chamber and committees

Work to improve gender identity healthcare services remains a priority of this Government. That includes the establishment of a multidisciplinary team of senior clinical advisers to Scottish Government who are considering the recommendations of the Cass Review in the contest of NHS services in Scotland. The Chief Medical Officer will provide a written update to Parliament on the outcome of that clinical consideration process before the summer recess. The outcome of that process will also feed into work on national commissioning of young person’s services.

The UK Government is the State Party to the CERD with a legal obligation to report on implementation. It submitted its state report to the Committee in March 2023.

Prior to this report’s submission, the Scottish Government shared updates on devolved policy areas including health, housing and employment with the UK Government. These updates were included in the UK Government’s report to the Committee.

Scotland is determined to play our part in eradicating racism, inequality and injustice – and in building a better, fairer world. Specifically, the Race Equality Framework demonstrates our commitment to eliminating racism – our Vision for a fairer Scotland is that by 2030 Scotland is a place where people are healthier, happier and treated with respect, and where opportunities, wealth and power are spread more equally.

The Scottish Government is working with Public Health Scotland to identify what data is already collected in Scotland on metastatic breast cancer and what data we would like to expand our datasets to include going forward.

The Scottish Government is reviewing options in relation to collecting data on secondary breast cancer in Scotland. This includes consideration of the NHS England audit, data available in Scotland, clinical time required, other cancer data priorities and how it can be used to improve services.

The Scottish Government has followed the publication of the National Audit of Metastatic Breast Cancer for England and Wales with interest. We are working with Public Health Scotland to determine our options for future data collection on metastatic breast cancer and its publication.

Up to 1,000 new applicants will be offered awards in 2024-25. The actual number of applications received will be monitored by ILF Scotland and Scottish Government.

The following table shows the resource funding allocated by SG to ILF Scotland annually over the last five years. Resource budget for ILF in 2024-25 is £62,241k. Funding for 2025-26 will be agreed through the annual budget process.

As of March 2024, 1,897 people in Scotland, and 344 people in Northern Ireland were in receipt of an Independent Living Fund award. These figures do not include Transition Fund awards.

The Scottish Government, along with Health Boards and the Centre for Sustainable Delivery (CfSD), is actively considering opportunities to allocate funding to deliver activity utilising the £30 million investment announced by the First Minister on 1 April. This funding is being targeted at a series of national and local plans to reduce backlogs in orthopaedics, ophthalmology, diagnostics and cancer backlog by maximising the use of local and national resources across Scotland.

Once we have concluded this process we will provide a breakdown of how the funding has been allocated by Health Board.

The initial £30 million of targeted investment is the first instalment of a £300 million plan over the next three years to help reduce waiting lists, subject to the Scottish Budget process.

Decisions on the Government’s spending plans for future years are subject to the outcome of the annual Scottish Budget setting process and associated approval by the Scottish Parliament. In-year revisions to the 2024-25 Scottish Budget are subject to parliamentary approval in the same way.

The Scottish Government, along with Health Boards and the Centre for Sustainable Delivery (CfSD), is actively considering opportunities to allocate funding to deliver activity utilising the £30 million investment announced by the First Minister on 1 April. This funding is being targeted at a series of national and local plans to reduce backlogs in orthopaedics, ophthalmology, diagnostics and cancer backlog by maximising the use of local and national resources across Scotland.

Once we have concluded this process we will provide a breakdown of how the funding has been allocated by Health Board.

The initial £30 million of targeted investment is the first instalment of a £300 million plan over the next three years to help reduce waiting lists, subject to the Scottish Budget process.

Decisions on the Government’s spending plans for future years are subject to the outcome of the annual Scottish Budget setting process and associated approval by the Scottish Parliament. In-year revisions to the 2024-25 Scottish Budget are subject to parliamentary approval in the same way.